A new study reveals that the BrECADD chemotherapy regimen for Hodgkin's lymphoma preserves fertility far better than standard treatments—without reducing survival rates. Learn how this breakthrough is changing cancer care.
Source: https://www.medicaldaily.com/new-hodgki ... val-473693
-
Translation